Here are 14 key notes on orthopedic and spine device companies from the past week.
The Internal Revenue Services is arguing in federal court to increase Medtronic's taxable income by around $1.4 billion related to its factories in Puerto Rico.
Medtronic reported second quarter worldwide revenue dropped 4 percent due to the company's divestiture of the Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses to Cardinal Health.
Medtronic unveiled new telehealth solutions as part of its U.S. Department of Veterans Affairs contract.
Stryker subsidiary Howmedica Osteonics, an orthopedics manufacturer, settled a trade secret disagreement with Zimmer Biomet.
Although reporting $19.7 billion total sales in the third quarter of 2017, Johnson & Johnson's spine division saw a decline in sales.
Globus Medical reported clinical results from its seven-year trial follow-up on the SECURE-C Cervical Artificial Disc, showing that patients with the SECURE-C reported greater overall satisfaction compared to ACDF patients.
Highmark issued a new medical policy that it the first private payer with exclusive positive coverage for Paradigm Spine's coflex Interlaminar Stabilization treatment for lumbar spinal stenosis.
Medicrea received FDA clearance for its IB3D range of 3-D printed titanium interbody devices and introduced AdapTEK.
Medicrea acquired three new patents related to interbody devices.
K2M, a company focused on achieving 3-D Total Body Balance, recorded its 300th surgical spine case using its Rhine Cervical Disc System.
With FDA approval of its Excelsius GPS in place, Globus Medical set itself up to stand as Mazor Robotics biggest rival in the spine market.
Four U.S. surgeons performed the first spine surgeries in the nation with Emerging Implant Technologies' implants.
SpineGuard received the first order of PediGuard in China from XinRong Medical Group.
ReWalk Robotics opened a public offering Nov. 17.